Iradimed (IRMD) Total Liabilities (2013 - 2026)

Iradimed (IRMD) has reported Total Liabilities for 14 consecutive years, with $13.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Liabilities rose 8.9% year-over-year to $13.2 million in Q2 2026; TTM through Jun 2026 was $13.2 million, a 8.9% increase from a year earlier, with the FY2025 full-year figure at $14.2 million, up 23.04% from the prior year.
• Total Liabilities was $13.2 million for Q2 2026 at Iradimed, down from $15.9 million in the prior quarter.
• Over five years, Total Liabilities peaked at $20.7 million in Q4 2023 and troughed at $9.8 million in Q3 2022.
• A 5-year average of $12.6 million and a median of $11.9 million in 2022 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 75.12% in 2023 and slumped 44.51% in 2024, its largest moves.
• Over 5 years, Total Liabilities stood at $11.8 million in 2022, then jumped by 75.12% to $20.7 million in 2023, then tumbled by 44.51% to $11.5 million in 2024, then climbed by 23.04% to $14.2 million in 2025, then fell by 6.58% to $13.2 million in 2026.
• The last three Total Liabilities figures came in at $13.2 million (Q2 2026), $15.9 million (Q1 2026), and $14.2 million (Q4 2025), per Business Quant data.